# Comparing Irinotecan and 5 FU/FA To 5-FU/FA After Resection Of Liver Metastases For Colorectal Cancer

> **NCT00143403** · PHASE3 · COMPLETED · sponsor: **Pfizer** · enrollment: 321 (actual)

## Conditions studied

- Colorectal Neoplasms
- Liver Neoplasms

## Interventions

- **DRUG:** Irinotecan + 5 FU + folinic acid
- **DRUG:** Folinic Acid + 5 FU

## Key facts

- **NCT ID:** NCT00143403
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-12
- **Primary completion:** 2008-02
- **Final completion:** 2009-09
- **Target enrollment:** 321 (ACTUAL)
- **Last updated:** 2010-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00143403

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00143403, "Comparing Irinotecan and 5 FU/FA To 5-FU/FA After Resection Of Liver Metastases For Colorectal Cancer". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00143403. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*